Zonisamide Capsule
Product Images NDC 68462-128

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 68462-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label100mg100s

Label for Zonisamide Capsules, USP 100 mg oral capsules by Glenmark Pharmaceuticals Inc., USA. The label includes dosage form, strength, package count of 100 capsules, storage instructions, and product safety warnings. It features the Glenmark logo and contact information.*

FDA Label Image

Label25mg100s

Zonisamide Capsules USP 25 mg label from Glenmark Pharmaceuticals Inc., USA. The label indicates a package of 100 oral capsules with dosage and storage instructions, barcode, and contact information for the manufacturer.*

FDA Label Image

Label50mg100s

Label for Zonisamide Capsules, USP 50 mg oral capsules by Glenmark Pharmaceuticals Inc. The label shows the NDC 68462-129-01 and indicates a package size of 100 capsules. It includes pharmacist instructions to dispense the Medication Guide separately, storage information, manufacturer details, and a barcode.*

FDA Label Image

Structure

Chemical structure of zonisamide, depicting the molecular arrangement including a benzisoxazole ring with a methanesulfonamide group attached.*

FDA Label Image

Figure 1

A comparative line graph showing the percentage reduction in all partial seizure rates versus the percentage of patients for two treatment arms: Zonisamide and Placebo. The y-axis represents the percent reduction ranging from worsening to improvement, while the x-axis represents the percentage of patients. The graph indicates greater seizure rate reduction for the Zonisamide group compared to the placebo group across most patient percentages.*

FDA Label Image

Logo Glen

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.